M. Iitaka et al., A CASE OF GRAVES-DISEASE WITH FALSE HYPERTHYROTROPINEMIA WHO DEVELOPED SILENT THYROIDITIS, Endocrinologia Japonica, 38(6), 1991, pp. 667-671
We encountered a patient who developed silent thyroiditis during the c
ourse of Graves' disease. The diagnosis of silent thyroiditis was made
on the basis of a low thyroidal I-131 uptake, no response to the thyr
otropin releasing hormone (TRH) test, and subsequent hypothyroidism de
spite the presence of high titers of thyrotropin (TSH) receptor antibo
dy (TRAb) and thyroid stimulating antibody (TSAb). The patient, in add
ition, had a discrepancy between serum TSH and thyroid hormone values.
This was due to the presence of interfering substances that react to
mouse IgG in the sera since serum TSH levels were decreased in a dose
dependent manner by the addition of increasing amounts of mouse IgG to
the sera. It should therefore be noted that silent thyroiditis can de
velop in patients with Graves' disease. Furthermore, clinicians should
be aware that two-site immunoassay kits that use mouse monoclonal ant
ibodies are subject to interference by some substances, possibly antib
odies which react to mouse IgG.